Menlo Therapeutics (MNLO) PT Raised to $3 at Barclays
Tweet
Share
E-mailGet Alerts MNLO Hot Sheet
Price: $1.35 --0%
Rating Summary:
9 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
9 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Barclays analyst Balaji Prasad raised the price target on Menlo Therapeutics (NASDAQ: MNLO) to $3.00 (from $2.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- JPMorgan Upgrades Hyundai Marine and Fire Insurance (001450:KS) to Neutral
- Samsonite International SA (1910:HK) (SMSEY) PT Lowered to HK$19.60 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
